Digital Look

Welcome to Digital Look++,
you are not logged in

Nektar Therapeutics (NKTR)

$ 44.47

Dennis Winger Joins Nektar Therapeutics' Board o...	14-Dec-2009	PR Newswire
Nektar Therapeutics Promotes Lorianne Masuoka, M...	30-Nov-2009	PR Newswire
Nektar Therapeutics Reports Third Quarter 2009 F...	04-Nov-2009	PR Newswire
Nektar to Announce Financial Results for the Thi...	29-Oct-2009	PR Newswire
Nektar Completes Enrollment Ahead of Schedule in...	28-Oct-2009	PR Newswire
Phase 2 Data From Oral NKTR-118 Presented at Ame...	27-Oct-2009	PR Newswire
Topline Results from Phase 2 Clinical Trial of O...	10-Oct-2009	PR Newswire
NKTR-102 Shows Encouraging Anti-Tumor Activity i...	22-Sep-2009	PR Newswire
Nektar Therapeutics to Host Conference Call to D...	21-Sep-2009	PR Newswire
Nektar Therapeutics to Present at the UBS 2009 G...	18-Sep-2009	PR Newswire
Nektar Presents Data Demonstrating Favorable Ora...	13-Sep-2009	PR Newswire
Nektar Therapeutics Reports Second Quarter 2009 ...	04-Aug-2009	PR Newswire
Nektar Therapeutics to Present at the BMO Capita...	31-Jul-2009	PR Newswire
Nektar to Announce Financial Results for the Sec...	31-Jul-2009	PR Newswire
Nektar Therapeutics Promotes Lorianne Masuoka, M...	09-Jun-2009	PR Newswire
Nektar Announces UCB's Cimzia(R) Approved by U.S...	14-May-2009	PR Newswire
Nektar Therapeutics to Present at the Deutsche B...	12-May-2009	PR Newswire
Nektar Therapeutics Reports First Quarter 2009 F...	06-May-2009	PR Newswire
Nektar to Announce Financial Results for the Fir...	30-Apr-2009	PR Newswire
NKTR-105 Demonstrates Superior Antitumor Activit...	22-Apr-2009	PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.